Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy

AIDS. 2001 Nov 23;15(17):2325-7. doi: 10.1097/00002030-200111230-00017.

Authors

A Antinori¹, G Liuzzi, A Cingolani, A Bertoli, S Di Giambenedetto, M P Trotta, M G Rizzo, E Girardi, A De Luca, C F Perno

Affiliation

¹ Lazzaro Spallanzani National Institute for Infectious Diseases, IRCCS, Rome, Italy.

PMID: 11698709
DOI: 10.1097/00002030-200111230-00017

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes / cytology
CD4-Positive T-Lymphocytes / immunology
Drug Resistance, Viral / genetics*
Female
HIV Infections / drug therapy
HIV Infections / immunology
HIV Infections / virology*
HIV Protease / genetics*
HIV Reverse Transcriptase / genetics*
HIV-1 / drug effects
HIV-1 / enzymology*
HIV-1 / genetics
HIV-1 / immunology
Humans
Male
Point Mutation*
RNA, Viral / blood
Treatment Failure
Viral Load

Substances

RNA, Viral
HIV Reverse Transcriptase
HIV Protease